id,disease_progression_status,survival_status,clinical_response_rate_target_lasion,clinical_response_rate_non_target_lasion,clinical_response_rate_new_lasion,clinical_response_rate_result,radiological_response_rate_target_lasion,radiological_response_rate_non_target_lasion,radiological_response_rate_new_lasion,radiological_response_rate_result,pathological_response_rate_target_lasion,pathological_response_rate_non_target_lasion,pathological_response_rate_new_lasion,pathological_response_rate_result,time,registration_number,laterality,current_chemo_protocol,chemo_starting_date,chemo_cycle_no,chemo_detail,disease_progression_status_date,pfs,survival_status_date,overall_survival,clinical_response_rate_date,radiological_response_rate_date,pathological_response_rate_date,cancer_type,patient_id_id,patient_id_socio_economic_status_name,patient_id_unique_id,patient_id_name,patient_id_phone,patient_id_date_of_birth,patient_id_gender,patient_id_blood_group,patient_id_area,patient_id_police_station,patient_id_district,doctor_id_name,center_id_name,grade_name,line_of_treatment_name,diagnosis_disease_group_name,diagnosis_subgroup_diagnosis_disease_group_name,diagnosis_subgroup_name,diagnosis_primary_site_name,diagnosis_laterility_name,patient_id_socio_economic_status,grade,disease_progression_status_name,survival_status_name,clinical_response_rate_target_lasion_name,clinical_response_rate_non_target_lasion_name,clinical_response_rate_new_lasion_name,clinical_response_rate_result_name,radiological_response_rate_target_lasion_name,radiological_response_rate_non_target_lasion_name,radiological_response_rate_new_lasion_name,radiological_response_rate_result_name,diagnosis_laterility,line_of_treatment,diagnosis_subgroup,pathological_response_rate_target_lasion_name,pathological_response_rate_non_target_lasion_name,pathological_response_rate_new_lasion_name,pathological_response_rate_result_name,diagnosis_disease_group,diagnosis_primary_site,name,value,unit,date,patient_observation_id
292,,,,,,,,,,,,,,,2024-06-12T16:54:46+06:00,BSH - H12109192691,Left,,,,"Started neoadjuvant chemotherapy with Doxorubicin 100 mg & Cyclophosphamide at
NUH on 24.11.22> started ChT with paclitaxel+Trastuzumab on 23.02.23",,,2023-04-19,,,,,Breast,283,Upper middle class,BSBSC-240000283,AJUMAN ARA JESSIE,1747753854,1974-09-02,Female,,,,,Prof Dr Qamruzzaman Chowdhury,BSH,3.0,,C50- Malignant neoplasm of breast,C50- Malignant neoplasm of breast,C50.2- Upper-inner quadrant of breast,Breast,Left,,,,Alive,,,,,,,,,,,,,,,,,,,,,,
340,,,,,,,,,,,,,,,2024-06-12T16:54:46+06:00,BSH - ,Left,,,,"Started neoadjuvant chemotherapy with Doxorubicin 100 mg & Cyclophosphamide at
NUH on 24.11.22> started ChT with paclitaxel+Trastuzumab on 23.02.23",,,2023-04-19,,,,,Breast,283,Upper middle class,BSBSC-240000283,AJUMAN ARA JESSIE,1747753854,1974-09-02,Female,,,,,Dr Md Arifur Rahman,BSH,3.0,,C50- Malignant neoplasm of breast,C50- Malignant neoplasm of breast,C50.2- Upper-inner quadrant of breast,Breast,Left,,,,Alive,,,,,,,,,,,,,,,,,,,,,,
